SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma-Reference-Cited by-同舟云学术

SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma

Published:2019-12-05 Issue:2 Volume:55 Page:1901858
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Cabrera Claudia S.,Nan Cassandra,Lindarck Niklas,Beekman Maarten J.H.I.,Arnetorp Sofie,van der Valk Ralf J.P.

Funder

AstraZeneca

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference16 articles.

1. Global Asthma Network. The Global Asthma Report 2018. http://www.globalasthmareport.org Date last updated: 31 August, 2018. Date last accessed: 21 July, 2019.

2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2019. https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf Last updated: June 2019. Date last accessed: 21 July, 2019.

3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2018. https://ginasthma.org/archived-reports/ Date last updated: 31 August, 2018. Date last accessed: 21 July, 2019.

4. British Thoracic Society. Scottish Intercollegiate Guidelines Network: British Guideline on the Management of Asthma. 2014. https://www.brit-thoracic.org.uk/qualityimprovement/guidelines/asthma/ Last updated: October 2014. Date last accessed: 21 July, 2019.

5. The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SABA prescriptions and asthma management practices in Singapore: results from a cross-sectional, observational SABINA III study;BMJ Open;2024-06

2. SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population;BMC Pulmonary Medicine;2024-05-14

3. Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil;Jornal Brasileiro de Pneumologia;2024-01-17

4. Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III;The Korean Journal of Internal Medicine;2024-01-01

5. Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia;World Allergy Organization Journal;2023-10